Video

Q&A With Matt Oster From Emory University: Finding Best Practices For Screening and Treating Young Cardiac Disease Patients

Author(s):

For children born with single ventricle defects every day matters in getting the treatment and operations they need to survive. A new study looked at a commonly known medication which could help get them extra time for their treatment.

For children born with single ventricle defects every day matters in getting the treatment and operations they need to survive. A new study looked at a commonly known medication which could help get them extra time for their treatment.

Matt Oster, MD, MPH, from Emory University discussed the study of digoxin and what it could mean for patients during the American Heart Association's annual scientific sessions in Orlando.

Patients born with single ventricle defects often have other conditions and issues to deal with after their birth including neurological disorders. A recent study looked at how common this problem is and what can be done to best address these concerns.

While states around the country screen for critical congenital heart disease how they conduct that screening can vary as much as the states themselves. What that means for overall patient care is a matter of recent discussion in the field.

Related Videos
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
© 2024 MJH Life Sciences

All rights reserved.